0001578563-23-000067.txt : 20230815 0001578563-23-000067.hdr.sgml : 20230815 20230815174852 ACCESSION NUMBER: 0001578563-23-000067 CONFORMED SUBMISSION TYPE: 4 PUBLIC DOCUMENT COUNT: 1 CONFORMED PERIOD OF REPORT: 20230811 FILED AS OF DATE: 20230815 DATE AS OF CHANGE: 20230815 REPORTING-OWNER: OWNER DATA: COMPANY CONFORMED NAME: Bartholdson John A. CENTRAL INDEX KEY: 0001382909 FILING VALUES: FORM TYPE: 4 SEC ACT: 1934 Act SEC FILE NUMBER: 001-37844 FILM NUMBER: 231175965 MAIL ADDRESS: STREET 1: C/O STONINGTON PARTNERS, INC. STREET 2: 540 MADISON AVENUE, 25TH FLOOR CITY: NEW YORK STATE: NY ZIP: 10022 ISSUER: COMPANY DATA: COMPANY CONFORMED NAME: Bioventus Inc. CENTRAL INDEX KEY: 0001665988 STANDARD INDUSTRIAL CLASSIFICATION: SURGICAL & MEDICAL INSTRUMENTS & APPARATUS [3841] IRS NUMBER: 810980861 STATE OF INCORPORATION: DE FISCAL YEAR END: 1231 BUSINESS ADDRESS: STREET 1: 4721 EMPEROR BOULEVARD, SUITE 100 CITY: DURHAM STATE: NC ZIP: 27703 BUSINESS PHONE: (919) 474-6700 MAIL ADDRESS: STREET 1: 4721 EMPEROR BOULEVARD, SUITE 100 CITY: DURHAM STATE: NC ZIP: 27703 4 1 primary_doc.xml PRIMARY DOCUMENT X0508 4 2023-08-11 0 0001665988 Bioventus Inc. BVS 0001382909 Bartholdson John A. 4721 EMPEROR BOULEVARD, SUITE 100 DURHAM NC 27703 1 0 1 0 0 Class A Common Stock 2023-08-11 4 P 0 50037 4.5953 A 6818872 I See Footnotes Class A Common Stock 2023-08-14 4 P 0 14985 4.7883 A 6833857 I See Footnotes Class A Common Stock 7576 D The price reported in Column 4 is a weighted average price. These shares were purchased in multiple transactions ranging from $4.485 to $4.69, inclusive. Reporting Person undertakes to provide to the Issuer, any security holder of the Issuer, or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares purchased at each separate price within the ranges set forth in this footnote. Consists of (i) 4,624,431 shares of Class A Common Stock held by Juniper Targeted Opportunity Fund, L.P. ("Juniper Fund"), (ii) 2,133,576 shares of Class A Common Stock held by Juniper Targeted Opportunities, L.P. ("Juniper Targeted Opportunities"), on an aggregate basis following all transactions reported herein, and (iii) 75,850 shares of Class A Common Stock held by Juniper Multi-Strategy Fund, L.P. ("Juniper Multi-Strategy" and, together with Juniper Fund, Juniper Targeted Opportunities and Juniper Multi-Strategy, the "Juniper Entities"). Juniper HF Investors II, LLC ("Juniper HF II"), Juniper Targeted Opportunity Investors, LLC ("Juniper TO") and Juniper HF Investors, LLC ("Juniper HF") are each the general partner of Juniper Fund, Juniper Targeted Opportunities and Juniper Multi-Strategy, respectively. Juniper Investment Company, LLC ("Juniper Investment Company") provides investment advisory and management services and acts as the investment manager of Juniper Fund, Juniper Targeted Opportunities and Juniper Multi-Strategy. The Reporting Person is a managing member of Juniper Investment Company, Juniper HF II, Juniper TO and Juniper HF and shares voting and dispositive power with respect to the shares held by the Juniper Entities. The Reporting Person disclaims beneficial ownership of the securities reported herein except to the extent of his pecuniary interest therein. The price reported in Column 4 is a weighted average price. These shares were purchased in multiple transactions ranging from $4.75 to $4.80, inclusive. Reporting Person undertakes to provide to the Issuer, any security holder of the Issuer, or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares purchased at each separate price within the ranges set forth in this footnote. /s/Anthony D'Adamio, Attorney-in-Fact 2023-08-15